Elsayad, K.; Oertel, M.; König, L.; Hüske, S.; Le Ray, E.; Meheissen, M.A.M.; Elsaid, A.A.; Elfaham, E.; Debus, J.; Kirova, Y.;
et al. Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis. Cancers 2020, 12, 676.
https://doi.org/10.3390/cancers12030676
AMA Style
Elsayad K, Oertel M, König L, Hüske S, Le Ray E, Meheissen MAM, Elsaid AA, Elfaham E, Debus J, Kirova Y,
et al. Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis. Cancers. 2020; 12(3):676.
https://doi.org/10.3390/cancers12030676
Chicago/Turabian Style
Elsayad, Khaled, Michael Oertel, Laila König, Sebastian Hüske, Emmanuelle Le Ray, Mohamed A.M. Meheissen, Amr Abdelaziz Elsaid, Essam Elfaham, Jürgen Debus, Youlia Kirova,
and et al. 2020. "Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis" Cancers 12, no. 3: 676.
https://doi.org/10.3390/cancers12030676
APA Style
Elsayad, K., Oertel, M., König, L., Hüske, S., Le Ray, E., Meheissen, M. A. M., Elsaid, A. A., Elfaham, E., Debus, J., Kirova, Y., Herfarth, K., & Eich, H. T.
(2020). Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis. Cancers, 12(3), 676.
https://doi.org/10.3390/cancers12030676